Evaluation of Nephrocerebral Risk With the Use of Cystatin C in Patients With Chronic Kidney Disease
Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova - Russian Federation
doi 10.17116/jnevro201811809110
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2018
Authors
Publisher
Media Sphere Publishing Group